Skip to main content
. Author manuscript; available in PMC: 2010 Oct 5.
Published in final edited form as: Nano Today. 2009 Oct 5;4(5):414–428. doi: 10.1016/j.nantod.2009.07.004

Figure 4.

Figure 4

Five-parameter quantitative analysis of the three tissue specimens obtained from tumor biopsies clearly identified the differences in biomarker expression profiles between different types of breast cancers. Molecular fingerprinting might not only provide more accurate diagnosis and prognosis, but also identify suitable molecular targets for anti-cancer therapy [23].